Role of CYP2D6 testing in selection of endocrine therapy for breast cancer

Pharmacogenomics. 2007 Jan;8(1):1-3. doi: 10.2217/14622416.8.1.1.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents, Hormonal / pharmacology
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Breast Neoplasms / diagnosis
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / enzymology*
  • Cytochrome P-450 CYP2D6 / analysis
  • Cytochrome P-450 CYP2D6 / physiology*
  • Female
  • Humans

Substances

  • Antineoplastic Agents, Hormonal
  • Cytochrome P-450 CYP2D6